規制動向

FDA、EMA、TGA および世界の規制動向

#ANDA080256 ×

2026年8月30日•1分で読めます

FDA Approves Lilly Methyltestosterone Tablet ANDA080256 (Discontinued)

FDA approved Lilly's ANDA080256 for methyltestosterone tablets (10 mg and 25 mg) buccal/sublingual on Dec 22 1971; both products are now discontinued.